David Zaccardelli - Net Worth and Insider Trading
David Zaccardelli Net Worth
The estimated net worth of David Zaccardelli is at least $570 Million dollars as of 2024-11-05. David Zaccardelli is the President and CEO of Verona Pharma PLC and owns about 14,591,736 shares of Verona Pharma PLC (VRNA) stock worth over $567 Million. David Zaccardelli is the President & CEO of Dova Pharmaceuticals Inc and owns about 76,647 shares of Dova Pharmaceuticals Inc (DOVA) stock worth over $2 Million. David Zaccardelli is also the EVP & COO of United Therapeutics Corp and owns about 1,153 shares of United Therapeutics Corp (UTHR) stock worth over $441,484. Besides these, David Zaccardelli also holds Melinta Therapeutics Inc (MLNTQ) . Details can be seen in David Zaccardelli's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David Zaccardelli has not made any transactions after 2024-10-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David Zaccardelli
David Zaccardelli Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David Zaccardelli owns 4 companies in total, including Dova Pharmaceuticals Inc (DOVA) , Melinta Therapeutics Inc (MLNTQ) , and United Therapeutics Corp (UTHR) among others .
Click here to see the complete history of David Zaccardelli’s form 4 insider trades.
Insider Ownership Summary of David Zaccardelli
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| DOVA | Dova Pharmaceuticals Inc | 2019-11-12 | director & President & CEO |
| MLNTQ | Melinta Therapeutics Inc | 2019-06-11 | director |
| UTHR | United Therapeutics Corp | 2015-04-14 | EVP & Chief Operating Officer |
 | | 2024-10-25 | director & President and CEO |
David Zaccardelli Latest Holdings Summary
David Zaccardelli currently owns a total of 4 stocks. Among these stocks, David Zaccardelli owns 14,591,736 shares of Verona Pharma PLC (VRNA) as of October 25, 2024, with a value of $567 Million and a weighting of 99.55%. David Zaccardelli owns 76,647 shares of Dova Pharmaceuticals Inc (DOVA) as of October 1, 2019, with a value of $2 Million and a weighting of 0.38%. David Zaccardelli also owns 1,153 shares of United Therapeutics Corp (UTHR) as of April 14, 2015, with a value of $441,484 and a weighting of 0.08%. The other 1 stocks Melinta Therapeutics Inc (MLNTQ) have a combined weighting of 0% among all his current holdings.
Latest Holdings of David Zaccardelli
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| VRNA | Verona Pharma PLC | 2024-10-25 | 14,591,736 | 38.87 | 567,107,820 |
| DOVA | Dova Pharmaceuticals Inc | 2019-10-01 | 76,647 | 28.04 | 2,149,182 |
| UTHR | United Therapeutics Corp | 2015-04-14 | 1,153 | 382.90 | 441,484 |
| MLNTQ | Melinta Therapeutics Inc | 2018-05-29 | 9,300 | 0.11 | 1,023 |
Holding Weightings of David Zaccardelli
David Zaccardelli Form 4 Trading Tracker
According to the SEC Form 4 filings, David Zaccardelli has made a total of 18 transactions in Verona Pharma PLC (VRNA) over the past 5 years, including 0 buys and 18 sells. The most-recent trade in Verona Pharma PLC is the sale of 144,816 shares on October 25, 2024, which brought David Zaccardelli around $634,294.
According to the SEC Form 4 filings, David Zaccardelli has made a total of 0 transactions in Dova Pharmaceuticals Inc (DOVA) over the past 5 years. The most-recent trade in Dova Pharmaceuticals Inc is the sale of 5,275 shares on October 1, 2019, which brought David Zaccardelli around $147,172.
According to the SEC Form 4 filings, David Zaccardelli has made a total of 0 transactions in United Therapeutics Corp (UTHR) over the past 5 years. The most-recent trade in United Therapeutics Corp is the sale of 3,250 shares on April 14, 2015, which brought David Zaccardelli around $603,915.
More details on David Zaccardelli's insider transactions can be found in the Insider Trading History of David Zaccardelli table.Insider Trading History of David Zaccardelli
- 1
David Zaccardelli Trading Performance
GuruFocus tracks the stock performance after each of David Zaccardelli's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David Zaccardelli is 18.01%. GuruFocus also compares David Zaccardelli's trading performance to market benchmark return within the same time period. The performance of stocks bought by David Zaccardelli within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David Zaccardelli's insider trading performs compared to the benchmark.
Performance of David Zaccardelli
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 22.21 | | | | | |
| Relative Return to S&P 500(%) | 17.56 | | | | | |
David Zaccardelli Ownership Network
Ownership Network List of David Zaccardelli
Ownership Network Relation of David Zaccardelli
David Zaccardelli Owned Company Details
What does Dova Pharmaceuticals Inc do?
Who are the key executives at Dova Pharmaceuticals Inc?
David Zaccardelli is the director & President & CEO of Dova Pharmaceuticals Inc. Other key executives at Dova Pharmaceuticals Inc include 10 percent owner Joseph Edelman , 10 percent owner Perceptive Advisors Llc , and 10 percent owner Perceptive Life Sciences Master Fund Ltd .
Dova Pharmaceuticals Inc (DOVA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Dova Pharmaceuticals Inc (DOVA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Dova Pharmaceuticals Inc (DOVA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Dova Pharmaceuticals Inc (DOVA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Dova Pharmaceuticals Inc Insider Transactions
David Zaccardelli Mailing Address
Above is the net worth, insider trading, and ownership report for David Zaccardelli. You might contact David Zaccardelli via mailing address: 300 Tri State International, Suite 272, Lincolnshire Il 60069.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
